Literature DB >> 10931799

Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial.

B F Uretsky1, K Thygesen, P W Armstrong, J G Cleland, J D Horowitz, B M Massie, M Packer, P A Poole-Wilson, L Ryden.   

Abstract

BACKGROUND: Sudden unexpected death frequently occurs in chronic heart failure. The importance of acute coronary events in triggering sudden death (SD) is unclear. METHODS AND
RESULTS: We evaluated at autopsy the prevalence of acute coronary findings (coronary thrombus, ruptured plaque, or myocardial infarction [MI]) and their relation to SD. Autopsy results in 171 patients in the randomized ATLAS trial were reviewed. The prevalence of acute coronary findings was 33%: in 54% of patients with significant coronary artery disease (CAD) who died suddenly, 32% who died of myocardial failure, but in non-CAD patients, they were present in only 5% and 10% respectively. The percentage of patients classified as dying of MI was 28% in the autopsy group versus 4% in the nonautopsied group (P<0.0001). Of the autopsied group with acute MI, 97% (31 of 32 patients) with SD and 40% (6 of 15 patients) with myocardial failure did not have the MI diagnosed during life. When undiagnosed MI was classified as "sudden unexpected" or "myocardial failure" from clinical information only, the distribution of death causes was similar in the autopsy and nonautopsied groups.
CONCLUSIONS: Acute coronary findings are frequent and usually not clinically diagnosed in heart failure patients with CAD, particularly in those dying suddenly, suggesting the importance of acute coronary events as a trigger for SD in this setting.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931799     DOI: 10.1161/01.cir.102.6.611

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  56 in total

Review 1.  Implications of recent heart failure trials for patients with hypertension.

Authors:  P A Poole-Wilson
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

Review 2.  Cardiovascular magnetic resonance and the evaluation of heart failure.

Authors:  James C C Moon; Sanjay K Prasad
Journal:  Curr Cardiol Rep       Date:  2005-01       Impact factor: 2.931

3.  Facts and principles learned at the 31st Annual Williamsburg Conference on Heart Disease.

Authors:  Mark A Peterman; Hassan Farooq; William C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-04

4.  Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy.

Authors:  R Klingenberg; C Zugck; R Becker; D Schellberg; G Heinze; R Kell; A Remppis; W Schoels; H A Katus; T J Dengler
Journal:  Heart       Date:  2006-09       Impact factor: 5.994

5.  Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Authors:  Michael Clearfield
Journal:  Curr Atheroscler Rep       Date:  2009-01       Impact factor: 5.113

Review 6.  Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure.

Authors:  Mihai Gheorghiade; Muthiah Vaduganathan; Andrew Ambrosy; Michael Böhm; Umberto Campia; John G F Cleland; Francesco Fedele; Gregg C Fonarow; Aldo P Maggioni; Alexandre Mebazaa; Mandeep Mehra; Marco Metra; Savina Nodari; Peter S Pang; Piotr Ponikowski; Hani N Sabbah; Michel Komajda; Javed Butler
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

Review 7.  Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance.

Authors:  Annamalai Senthilkumar; Maulik D Majmudar; Chetan Shenoy; Han W Kim; Raymond J Kim
Journal:  Heart Fail Clin       Date:  2009-07       Impact factor: 3.179

8.  Use of novel oral anticoagulants in patients with heart failure.

Authors:  Eduard Shantsila; Gregory Y H Lip
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-02

9.  Mode of death in heart failure: findings from the ATLAS trial.

Authors:  P A Poole-Wilson; B F Uretsky; K Thygesen; J G F Cleland; B M Massie; L Rydén
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

10.  Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study.

Authors:  A M A Shehab; R J MacFadyen; M McLaren; R Tavendale; J J F Belch; A D Struthers
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.